Objective: The purpose of this research is to see how coronavirus affects people with cirrhosis, a type of chronic liver disease.

Study Design: Retrospective/observational

Place and Duration: Conducted at Khyber Teaching Hospital Peshawar, during from April 2021 to Oct 2021.

Methodology: This study included 100 covid-19 individuals of both genders with or without chronic liver disease. There were two groups of patients.  Group I (50 patients with cirrhosis) and Group II (without cirrhosis 50 patients). The mortality outcomes of the two groups were compared. SPSS 25.0 was used to analyze all of the data.

Results: There were 31 (62%) males and 19 (38%) were females with mean age 43.31±=7.61 years in group I while in group II 32 (64%) and 18 (36%) patients were males and females with mean age 46.01±5.23 years. Patients with cirrhosis died at a higher rate than those without it, with a p-value of 0.0001 (34 percent vs. 10%).

Conclusion: Patients with cirrhosis who also had coronavirus illness had a higher incidence of poor outcomes.